CRBU
Price
$1.98
Change
-$0.02 (-1.00%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
184.38M
76 days until earnings call
GYRE
Price
$8.12
Change
+$0.36 (+4.64%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
736.61M
77 days until earnings call
Interact to see
Advertisement

CRBU vs GYRE

Header iconCRBU vs GYRE Comparison
Open Charts CRBU vs GYREBanner chart's image
Caribou Biosciences
Price$1.98
Change-$0.02 (-1.00%)
Volume$8.56K
Capitalization184.38M
Gyre Therapeutics
Price$8.12
Change+$0.36 (+4.64%)
Volume$2.32K
Capitalization736.61M
CRBU vs GYRE Comparison Chart in %
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. GYRE commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Buy and GYRE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (CRBU: $1.98 vs. GYRE: $8.11)
Brand notoriety: CRBU and GYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 77% vs. GYRE: 88%
Market capitalization -- CRBU: $184.38M vs. GYRE: $736.61M
CRBU [@Biotechnology] is valued at $184.38M. GYRE’s [@Biotechnology] market capitalization is $736.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileGYRE’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • GYRE’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than GYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while GYRE’s TA Score has 5 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 5 bearish.
  • GYRE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GYRE is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а +10.00% price change this week, while GYRE (@Biotechnology) price change was +4.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.04%. For the same industry, the average monthly price growth was +19.75%, and the average quarterly price growth was +30.54%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 11, 2025.

GYRE is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GYRE($737M) has a higher market cap than CRBU($184M). CRBU YTD gains are higher at: 25.786 vs. GYRE (-35.868). GYRE has higher annual earnings (EBITDA): 11.5M vs. CRBU (-150.76M). CRBU has more cash in the bank: 184M vs. GYRE (54.4M). GYRE has less debt than CRBU: GYRE (1.39M) vs CRBU (25.9M). GYRE has higher revenues than CRBU: GYRE (102M) vs CRBU (9.12M).
CRBUGYRECRBU / GYRE
Capitalization184M737M25%
EBITDA-150.76M11.5M-1,311%
Gain YTD25.786-35.868-72%
P/E RatioN/A405.50-
Revenue9.12M102M9%
Total Cash184M54.4M338%
Total Debt25.9M1.39M1,859%
FUNDAMENTALS RATINGS
GYRE: Fundamental Ratings
GYRE
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUGYRE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISTNX87.600.53
+0.61%
Macquarie Science and Technology R6
HUMDX16.71N/A
N/A
Huber Mid Cap Value Inv
VYSEX15.39N/A
N/A
Voya Small Company R6
VSRDX19.33N/A
N/A
VALIC Company I U.S. Socially Rspnb
IUAEX28.83-0.02
-0.07%
JPMorgan International Focus A

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+6.38%
CRSP - CRBU
60%
Loosely correlated
+1.39%
BEAM - CRBU
56%
Loosely correlated
+1.22%
FATE - CRBU
54%
Loosely correlated
+1.83%
MGNX - CRBU
54%
Loosely correlated
+10.37%
RXRX - CRBU
53%
Loosely correlated
N/A
More

GYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GYRE has been loosely correlated with SPRC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GYRE jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GYRE
1D Price
Change %
GYRE100%
-5.37%
SPRC - GYRE
38%
Loosely correlated
+0.24%
BEAM - GYRE
37%
Loosely correlated
+1.22%
RCKT - GYRE
36%
Loosely correlated
-4.24%
AURA - GYRE
36%
Loosely correlated
-0.31%
CRBU - GYRE
35%
Loosely correlated
+6.38%
More